Alerus Investment Advisors’s Gilead Sciences GILD Stock Holding History

Alerus Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$441K	Buy	4,798 +158	+3%	+$14.2K	0.08%	109
2015 Q4	$470K	Hold	4,640	–	–	0.08%	109
2015 Q3	$456K	Hold	4,640	–	–	0.08%	101
2015 Q2	$455K	Hold	4,640	–	–	0.08%	106
2015 Q1	$455K	Hold	4,640	–	–	0.08%	106
2014 Q4	$437K	Sell	4,640 -8	-0.2%	-$827	0.07%	107
2014 Q3	$495K	Sell	4,648 -17	-0.4%	-$1.67K	0.09%	104
2014 Q2	$387K	Buy	4,665 +25	+0.5%	+$1.95K	0.07%	109
2014 Q1	$329K	Hold	4,640	–	–	0.07%	115
2013 Q4	$348K	Hold	4,640	–	–	0.08%	111
2013 Q3	$292K	Hold	4,640	–	–	0.06%	113
2013 Q2	$238K	Buy	+4,640	New	+$242K	0.04%	123

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alerus Investment Advisors's GILD Position: Q1 2016 in Review

Alerus Investment Advisors increased its Gilead Sciences (GILD) stake by 3.4% in Q1 2016, buying an estimated $14.2K and bringing the position to 4,798 shares worth $441K. The position accounts for 0.08% of the portfolio, ranked #109.

Alerus Investment Advisors first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $495K in Q3 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Alerus Investment Advisors held 4,798 shares of Gilead Sciences worth $441K as of Q1 2016.
Alerus Investment Advisors bought 158 Gilead Sciences shares in Q1 2016, an estimated $14.2K.
Gilead Sciences made up 0.08% of Alerus Investment Advisors's portfolio in Q1 2016, its #109 holding.
Alerus Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
Alerus Investment Advisors's Gilead Sciences position peaked at $495K in Q3 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.